Revolutionary study: stem cell rejuvenation could bring healing!

Revolutionary study: stem cell rejuvenation could bring healing!

Laimgrubengasse 10, 1060 Wien, Österreich - researchers of the Children’s Hospital of Philadelphia (Chop) are faced with a breakthrough in medicine! Turn Biotechnologies presented a revolutionary study to evaluate ERA ™ therapy, which aims to rejuvenate bone marrow stem cells. This epigenetic reprogramming could be crucial to offer patients better healing opportunities after a stem cell transplantation and to significantly increase the quality of the transplanted cells. With the support of the Methuselah Foundation, it is examined how the rejuvenation of the stem cells can improve the production of crucial immune cells. According to Timothy Olson, the senior test doctor, older stem cells could reduce the risk of diseases such as leukemia if they are rejuvenated.

new ways to cell rejuvenation

The blood predecessor cells examined in the one-year study come from mice and are transplanted to test the effectiveness of the ERA solution. David Gobel, CEO of Methuselah Foundation, is optimistic that this research could not only revolutionize medical practice, but also has the potential to extend human life. But that's not all: Turn biotechnologies recently received positive feedback on their therapy TRN-001 during an FDA Interact session, which is supposed to repair damaged skin cells at cellular level. To this end, the company uses its innovative ERA ™ technology to ensure that the treatment is used specifically and effectively.

The combination of these two study positions shows the enormous growth potential for turn biotechnologies in cell rejuvenation therapy. Anja Krammer, CEO of Turn Bio, was pleased with the positive feedback from the FDA and sees the company in an excellent position in order to be the first company to introduce cell rejuvenation therapy in clinical applications. This could be crucial to combat chronic, age -related diseases and improve the quality of life of millions of people, while it is expanding the opportunities for future medical progress, as from OTS and PR Newswire reported.